Liver Encephalopathy
Links shared publicly online about this topic
Encephalopathy, Hepatic: eMedicine Gastroenterology
emedicine.medscape.com — “Overview: Definition Hepatic encephalopathy is a syndrome observed in patients with cirrhosis. Hepatic encephalopathy is defined as a spectrum of neuropsychiatric abnormalities in patients with liver dysfunction, after exclusion of other known brain disease. Hepatic encephalopathy is characterized by ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:58 pm By:
Hepatic encephalopathy is a syndrome observed in patients with cirrhosis. Learn more about hepatic encephalopathy. http://bit.ly/csoGNV
Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality - Brandman - 2011 - Liver International - Wiley Online Library
onlinelibrary.wiley.com — “Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality - Brandman - 2011 - Liver International - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on September 7, 2011 at 7:54 am By:
Pretransplant severe hepatic encephalopathy, peritransplant sodium and postâ€*liver transplantation morbidity an... http://t.co/YCaMiKA
Gastro Medical News about Hepatic Encephalopathy
mdlinx.com — “Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver” View full resource at mdlinx.com
Most Recently Shared on May 27, 2010 at 6:22 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for S... http://bit.ly/aSilHW #GI
Xifaxan 550mg approved to reduce risk of hepatic encephalopathy - MPR
empr.com — “The FDA has approved Xifaxan (rifaximin tablets, from Salix Pharmaceuticals) 550mg for the reduction in risk of recurrence of overt hepatic encephalopathy in patients 18 years of age with advanced liver disease.” View full resource at empr.com
Most Recently Shared on March 25, 2010 at 4:53 pm By:
MPR News: Xifaxan 550mg approved to reduce risk of hepatic encephalopathy: The FDA has approved Xifaxan (rifaximin... http://bit.ly/9mjmPG
Hepatitis-c and Alcohol Abuse | Hepatic Encephalopathy | Hepatitis
hepatitis.net16.net — “Since more than five million Americans with hepatitis B or C, two conditions that destroy the liver and kill thousands of people each year, can understand that.” View full resource at hepatitis.net16.net
Most Recently Shared on July 9, 2010 at 5:21 pm By:
Peter H Brown Doctor and Psychologist
Hepatitis-c and Alcohol Abuse | Hepatic Encephalopathy | Hepatitis http://bit.ly/cHzcve
Acute Liver Failure: eMedicine Gastroenterology
emedicine.medscape.com — “Overview: Acute liver failure (ALF) is an uncommon condition in which the rapid deterioration of liver function results in coagulopathy and alteration in the mental status of a previously healthy individual. Acute liver failure often affects young ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:47 pm By:
Susan Scroggins Active Health Library and Health Advocate
Acute liver failure often affects young people and carries a very high mortality. Learn more about causes. http://bit.ly/c5H34p
FDA Approves New Use of Xifaxan for Patients with Liver Disease
drugs.com — “Xifaxan (rifaximin) is used to treat traveler's diarrhea and to reduce risk of hepatic encephalopathy in patients with advanced liver disease. Includes Xifaxan side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 29, 2010 at 9:53 pm By:
FDA Approves New Use of Xifaxan for Patients with Liver Disease - http://bit.ly/djxsxB
FDA Approves New Use Of Xifaxan For Patients With Liver Disease
medicalnewstoday.com — “The U.S. Food and Drug Administration approved the use of Xifaxan for reduction in the risk of the recurrence of overt hepatic encephalopathy (HE) in patients with advanced liver disease. This is” View full resource at medicalnewstoday.com
Most Recently Shared on March 26, 2010 at 3:14 pm By:
MNT Drug Approvals Health News
FDA Approves New Use Of Xifaxan For Patients With Liver Disease http://mnt.to/3ztP #regulatory
Gastro Medical News about Liver Cirrhosis
mdlinx.com — “Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver” View full resource at mdlinx.com
Most Recently Shared on June 5, 2010 at 2:43 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver: Di... http://bit.ly/aWTeCM #GI
Portal-Systemic Encephalopathy: eMedicine Gastroenterology
emedicine.medscape.com — “Overview: Portosystemic encephalopathy (PSE) or hepatic encephalopathy (HE) is a neuropsychiatric syndrome associated with hepatocellular failure or portal-systemic venous shunting. There has been a lack of standardization of terminology used to define hepatic encephalopathy. Acute hepatic encephalopathy ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:41 pm By:
Susan Scroggins Active Health Library and Health Advocate
Portosystemic encephalopathy is a neuropsychiatric syndrome associated w/ ehpatocellular failure. Learn more. http://bit.ly/cdCgU3
Device could help liver failure patients, extend options for transplant
physorg.com — “For patients with acute alcoholic hepatitis (AAH), inflammation of the liver can result in a multitude of symptoms, including jaundice, fluid accumulation in the abdomen and hepatic encephalopathy -- impaired brain function leading to irritability, tremors and confusion.” View full resource at physorg.com
Most Recently Shared on March 11, 2011 at 3:45 pm By:
PhysOrg Health News Health News
Device could help liver failure patients, extend options for transplant http://tw.physorg.com/219062482
Ocera Therapeutics Completes First In Human Studies With OCR-002 For The Treatment Of Hyperammonemia And Hepatic Encephalopathy
medicalnewstoday.com — “Ocera Therapeutics, Inc. announced that it has completed two studies evaluating the safety and pharmacokinetics of OCR-002 (ornithine phenylacetate) which includes healthy volunteers and patients” View full resource at medicalnewstoday.com
Most Recently Shared on December 16, 2010 at 5:05 pm By:
Ocera Therapeutics Completes First In Human Studies With OCR-002 For The Treatment Of Hyperammonemia And Hepatic Encep... http://mnt.to/3P9W
Doctors should evaluate liver disease patients for cognitive impairment, address driving safety - News - Virtual Medical Centre
virtualmedicalcentre.com — “There are potential legal ramifications for physicians of patients who drive with cognitive impairment. About half of patients with cirrhosis are affected by a peculiar kind of cognitive impairment, also known as hepatic encephalopathy.” View full resource at virtualmedicalcentre.com
Most Recently Shared on April 3, 2011 at 2:03 pm By:
VirtualMedicalCentre Health Site
Doctors should evaluate liver disease patients for cognitive impairment, address driving safety http://dlvr.it/ML3G7 #Healthnews
Alcoholic Hepatitis: eMedicine Gastroenterology
emedicine.medscape.com — “Overview: Alcoholic hepatitis is a syndrome of progressive inflammatory liver injury associated with long-term heavy intake of ethanol. The pathogenesis is not completely understood.1Patients who are severely affected present with subacute onset of fever, hepatomegaly, leukocytosis, ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:16 pm By:
Susan Scroggins Active Health Library and Health Advocate
Alcoholic hepatitis is a syndrome of progressive inflammatory liver injury associated with long-term heavy drinking. http://bit.ly/9LUFHt
Gastro Medical News about Cirrhosis
mdlinx.com — “Portosystemic Encephalopathy Due to Mesoiliac Shunt in a Patient Without Cirrhosis” View full resource at mdlinx.com
Most Recently Shared on April 28, 2010 at 6:27 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Portosystemic Encephalopathy Due to Mesoiliac Shunt in a Patient Without Cirrhosis: Journal of Clinical Gastroe... http://bit.ly/cx9557 #GI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
OrganizedWisdom GI
Organizing gastroenterology and digestion resources shared by health experts, advocates, and organizations into WisdomCards.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
